Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,001,343
+$36,639,876 QoQ
Shares Held
2,068,992
+18.6% QoQ
Ownership
2.82%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#9
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Derivatives in ELVN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,654,000
PutShares
72,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ELVN ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in ELVN
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,001,343 | 2,068,992 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $3,654,000 | 72,000 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $68,361,467 | 1,743,915 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $3,586,800 | 91,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,415,120 | 36,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $272,580 | 17,700 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $21,934,897 | 1,424,344 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,755,496 | 1,160,503 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,496,704 | 1,470,424 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,936 | 200 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $22,103,355 | 1,123,138 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $17,712 | 900 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $39,116,969 | 1,738,532 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $6,750 | 300 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $24,750 | 1,100 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $12,770 | 500 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $2,554 | 100 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $44,285,772 | 1,733,977 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $84,132 | 3,600 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $14,022 | 600 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $53,933,613 | 2,307,814 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,413,948 | 2,354,403 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $33,139,159 | 2,394,448 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,390 | 175 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $32,121,367 | 2,351,491 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $46,865,646 | 2,296,210 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $3,571 | 175 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $55,297 | 2,525 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $5,475 | 250 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $50,286,999 | 2,296,210 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||